110 related articles for article (PubMed ID: 35538285)
1. Among Antibody-Like Molecules, Monobodies, Able to Interact with Nucleocapsid Protein of SARS-CoV Virus, There Are Monobodies with High Affinity to Nucleocapsid Protein of SARS-CoV-2 Virus.
Khramtsov YV; Ulasov AV; Lupanova TN; Georgiev GP; Sobolev AS
Dokl Biochem Biophys; 2022 Apr; 503(1):90-92. PubMed ID: 35538285
[TBL] [Abstract][Full Text] [Related]
2. Delivery of Antibody-Like Molecules, Monobodies, Capable of Binding with SARS-CoV-2 Virus Nucleocapsid Protein, into Target Cells.
Khramtsov YV; Ulasov AV; Lupanova TN; Georgiev GP; Sobolev AS
Dokl Biochem Biophys; 2022 Oct; 506(1):220-222. PubMed ID: 36303056
[TBL] [Abstract][Full Text] [Related]
3. Modular Nanotransporters Capable of Binding to SARS-CoV-2 Virus Nucleocapsid Protein in Target Cells.
Khramtsov YV; Ulasov AV; Lupanova TN; Georgiev GP; Sobolev AS
Dokl Biochem Biophys; 2023 Jun; 510(1):87-90. PubMed ID: 37582868
[TBL] [Abstract][Full Text] [Related]
4. Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern.
Kondo T; Matsuoka K; Umemoto S; Fujino T; Hayashi G; Iwatani Y; Murakami H
Life Sci Alliance; 2022 Jun; 5(6):. PubMed ID: 35256514
[TBL] [Abstract][Full Text] [Related]
5. A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein.
Li Z; Wang A; Zhou J; Chen Y; Liu H; Liu Y; Zhang Y; Ding P; Zhu X; Liang C; Qi Y; Liu E; Zhang G
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682904
[TBL] [Abstract][Full Text] [Related]
6. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
[TBL] [Abstract][Full Text] [Related]
7. Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody.
Terry JS; Anderson LB; Scherman MS; McAlister CE; Perera R; Schountz T; Geiss BJ
Virology; 2021 Jun; 558():28-37. PubMed ID: 33714753
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies.
Tian Y; Zhang G; Liu H; Ding P; Jia R; Zhou J; Chen Y; Qi Y; Du J; Liang C; Zhu X; Wang A
Appl Microbiol Biotechnol; 2022 Feb; 106(3):1151-1164. PubMed ID: 35037999
[TBL] [Abstract][Full Text] [Related]
9. Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes.
Lee JH; Jung Y; Lee SK; Kim J; Lee CS; Kim S; Lee JS; Kim NH; Kim HG
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215848
[TBL] [Abstract][Full Text] [Related]
10. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
[TBL] [Abstract][Full Text] [Related]
11. An easy pipeline for one-step purification of SARS-CoV-2 nucleocapsid protein from insect cell suspension culture.
de Camargo BR; da Silva LA; de Oliveira AS; Ribeiro BM
J Virol Methods; 2022 Jan; 299():114341. PubMed ID: 34699776
[TBL] [Abstract][Full Text] [Related]
12. Single-Domain Antibodies for the Detection of SARS-CoV-2 Nucleocapsid Protein.
Anderson GP; Liu JL; Esparza TJ; Voelker BT; Hofmann ER; Goldman ER
Anal Chem; 2021 May; 93(19):7283-7291. PubMed ID: 33955213
[TBL] [Abstract][Full Text] [Related]
13. Antigen production and development of an indirect ELISA based on the nucleocapsid protein to detect human SARS-CoV-2 seroconversion.
Conzentino MS; Forchhammer K; Souza EM; Pedrosa FO; Nogueira MB; Raboni SM; Rego FGM; Zanette DL; Aoki MN; Nardin JM; Fornazari B; Morales HMP; Celedon PAF; Lima CVP; Mattar SB; Lin VH; Morello LG; Marchini FK; Reis RA; Huergo LF
Braz J Microbiol; 2021 Dec; 52(4):2069-2073. PubMed ID: 34342836
[TBL] [Abstract][Full Text] [Related]
14. Modular Nanotransporters Capable of Causing Intracellular Degradation of the N-Protein of the SARS-CoV-2 Virus in A549 Cells with Temporary Expression of This Protein Fused with a Fluorescent Protein mRuby3.
Khramtsov YV; Ulasov AV; Lupanova TN; Georgiev GP; Sobolev AS
Dokl Biochem Biophys; 2023 Dec; 513(Suppl 1):S60-S62. PubMed ID: 38379080
[TBL] [Abstract][Full Text] [Related]
15. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
16. Antibody-like proteins that capture and neutralize SARS-CoV-2.
Kondo T; Iwatani Y; Matsuoka K; Fujino T; Umemoto S; Yokomaku Y; Ishizaki K; Kito S; Sezaki T; Hayashi G; Murakami H
Sci Adv; 2020 Oct; 6(42):. PubMed ID: 32948512
[TBL] [Abstract][Full Text] [Related]
17. IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients.
Yang L; Xu Q; Yang B; Li J; Dong R; Da J; Ye Z; Xu Y; Zhou H; Zhang X; Liu L; Zha Y; Yu F
BMC Microbiol; 2021 Dec; 21(1):351. PubMed ID: 34922455
[TBL] [Abstract][Full Text] [Related]
18. Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine.
Feng W; Xiang Y; Wu L; Chen Z; Li Q; Chen J; Guo Y; Xia D; Chen N; Zhang L; Zhu S; Zhao KN
J Clin Lab Anal; 2022 Jun; 36(6):e24479. PubMed ID: 35527696
[TBL] [Abstract][Full Text] [Related]
19. Construction, Characterization, and Application of a Nonpathogenic Virus-like Model for SARS-CoV-2 Nucleocapsid Protein by Phage Display.
Wu Y; Liu B; Liu Z; Zhang P; Mu X; Tong Z
Toxins (Basel); 2022 Oct; 14(10):. PubMed ID: 36287952
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D
Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
